Sensitive ASX Announcement

Cynata MSCs beneficial in preclinical ARDS study

Published: 17/04/20, 09:59am (AEST)2 pages
Cynata Therapeutics Limited
CYP:ASXHealthcare

Recent CYP Announcements

Price Sensitive only